These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10481843)

  • 1. MDMA study.
    Gijsman HJ; Verkes RJ; van Gerven JM; Cohen AF
    Neuropsychopharmacology; 1999 Oct; 21(4):597. PubMed ID: 10481843
    [No Abstract]   [Full Text] [Related]  

  • 2. Is a single dose of MDMA harmless?
    Vollenweider FX; Gamma A; Liechti M; Huber T
    Neuropsychopharmacology; 1999 Oct; 21(4):598-600. PubMed ID: 10481844
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroscience. Drug find could give ravers the jitters.
    Holden C
    Science; 2002 Sep; 297(5590):2185-7. PubMed ID: 12351758
    [No Abstract]   [Full Text] [Related]  

  • 4. MDMA ("ecstasy") and neurotoxicity.
    Mithoefer M; Jerome L; Doblin R
    Science; 2003 Jun; 300(5625):1504-5; author reply 1504-5. PubMed ID: 12791964
    [No Abstract]   [Full Text] [Related]  

  • 5. Caveat emptor: editors beware.
    McCann UD; Ricaurte GA
    Neuropsychopharmacology; 2001 Mar; 24(3):333-6. PubMed ID: 11256359
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-methylenedioxymethamphetamine (MDMA): a review.
    O'Leary G; Nargiso J; Weiss RD
    Curr Psychiatry Rep; 2001 Dec; 3(6):477-83. PubMed ID: 11707161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective neurocognitive deficits associated with multiple doses of ecstasy/MDMA: a reply to Cole.
    Fox HC; Parrott AC
    J Psychopharmacol; 2003 Jun; 17(2):242-4. PubMed ID: 12870575
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is the anxiety about Ecstasy justified?].
    Möller-Nehring E; Luderer HJ
    Fortschr Med; 1997 Mar; 115(7):28, 31-2, 34. PubMed ID: 9173018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical crossroads for MDMA.
    Guillot C
    J Psychoactive Drugs; 2005 Dec; 37(4):445-7. PubMed ID: 16480172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA and serotonin: based on two cases.
    Garcia Cabeza I; Zabala A; Soto-Montenegro ML; Arango C
    Actas Esp Psiquiatr; 2005; 33(5):339-42. PubMed ID: 16155817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ecstasy is a dangerous drug the society chooses to ignore].
    Heilig M
    Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic effect of MDMA on brain serotonin neurons.
    Reed LJ; Winstock A; Cleare AJ; McGuire P
    Lancet; 1999 Apr; 353(9160):1268; author reply 1270-1. PubMed ID: 10217101
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.
    Hayat S; Williams RJ; Rattray M
    J Psychopharmacol; 2006 Mar; 20(2):257-63. PubMed ID: 16510483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On ecstasy].
    Boulu R
    Ann Pharm Fr; 2003 May; 61(3):155-6. PubMed ID: 12714927
    [No Abstract]   [Full Text] [Related]  

  • 18. Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.
    Parrott AC
    Hum Psychopharmacol; 2013 Jul; 28(4):289-307. PubMed ID: 23881877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia.
    Capela JP; Meisel A; Abreu AR; Branco PS; Ferreira LM; Lobo AM; Remião F; Bastos ML; Carvalho F
    J Pharmacol Exp Ther; 2006 Jan; 316(1):53-61. PubMed ID: 16183702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
    Uys JD; Niesink RJ
    Drug Alcohol Rev; 2005 Jul; 24(4):359-68. PubMed ID: 16234132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.